BMRN - BioMarin Pharmaceutical Non-GAAP EPS of $0.71 beats by $0.11 revenue of $648.83M misses by $2.98M
2024-04-24 16:03:10 ET
More on BioMarin Pharmaceutical
- BioMarin Pharmaceutical: Still Has A Lot Of Room For Growth
- BioMarin Pharmaceutical Inc. 2023 Q4 - Results - Earnings Call Presentation
- BioMarin Pharmaceutical, Inc. (BMRN) Q4 2023 Earnings Call Transcript
- BioMarin Pharmaceutical Q1 2024 Earnings Preview
- DOJ reportedly subpoenas BioMarin over sponsored testing programs